ARIPIPRAZOLE ORAL

ARIPIPRAZOLE ORAL was reported 42262 times

ARIPIPRAZOLE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOPROLACTINAEMIA 27 0.5294
1 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 34 0.5075
2 BLOOD PROLACTIN ABNORMAL 423 0.4902
3 ANOSOGNOSIA 357 0.4648
4 DYSTONIC TREMOR 33 0.3750
5 BANKRUPTCY 143 0.3178
6 GAMBLING DISORDER 744 0.2751
7 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 180 0.2605
8 SCHIZOAFFECTIVE DISORDER 418 0.2342
9 COMPULSIVE HOARDING 70 0.2181
10 ACUTE MYOPIA 38 0.2088
11 COMPULSIVE SEXUAL BEHAVIOUR 163 0.2012
12 COMPULSIVE SHOPPING 397 0.1928
13 VICTIM OF CHILD ABUSE 48 0.1912
14 HOMELESS 85 0.1910
15 DELUSION OF GRANDEUR 84 0.1871
16 SHOPLIFTING 50 0.1805
17 DIVORCED 78 0.1769
18 CHILD ABUSE 45 0.1737
19 LACTATION INSUFFICIENCY 35 0.1691
20 EPIDURAL LIPOMATOSIS 55 0.1599
21 OCULOGYRIC CRISIS 326 0.1518
22 PSYCHOTIC SYMPTOM 311 0.1505
23 MYCOBACTERIUM FORTUITUM INFECTION 27 0.1459
24 DISTURBANCE IN SOCIAL BEHAVIOUR 341 0.1446
25 NEUTROPENIA NEONATAL 31 0.1390
26 EXCESSIVE MASTURBATION 26 0.1256
27 DISINHIBITION 199 0.1235
28 MALIGNANT CATATONIA 32 0.1217
29 HYPERSEXUALITY 221 0.1208
30 ORTHOSTATIC HYPERTENSION 70 0.1201
31 ANTIPSYCHOTIC DRUG LEVEL DECREASED 62 0.1168
32 NEGLECT OF PERSONAL APPEARANCE 28 0.1152
33 DECREASED EYE CONTACT 34 0.1118
34 OPPOSITIONAL DEFIANT DISORDER 43 0.1089
35 SCHIZOPHRENIA 1305 0.1073
36 DRUG-GENETIC INTERACTION 38 0.1064
37 SINUS RHYTHM 46 0.1057
38 SPASMODIC DYSPHONIA 32 0.1056
39 THEFT 69 0.1038
40 POST CHOLECYSTECTOMY SYNDROME 28 0.0989
41 POOR PERSONAL HYGIENE 51 0.0988
42 COGWHEEL RIGIDITY 100 0.0952
43 AKATHISIA 1194 0.0874
44 SELF-DESTRUCTIVE BEHAVIOUR 74 0.0849
45 GAMBLING 96 0.0823
46 SEDATION COMPLICATION 208 0.0814
47 OROMANDIBULAR DYSTONIA 59 0.0809
48 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 72 0.0808
49 NEUROLEPTIC MALIGNANT SYNDROME 952 0.0802
50 PERSECUTORY DELUSION 195 0.0781
51 SEXUALLY INAPPROPRIATE BEHAVIOUR 36 0.0773
52 METABOLIC SYNDROME 126 0.0766
53 IMPULSE-CONTROL DISORDER 157 0.0762
54 NEUROPSYCHIATRIC SYMPTOMS 67 0.0742
55 DERMATILLOMANIA 44 0.0738
56 SEXUALLY TRANSMITTED DISEASE 32 0.0736
57 PARKINSONISM 717 0.0735
58 METABOLIC DISORDER 426 0.0733
59 BINGE EATING 78 0.0723
60 GRANULOCYTE COUNT INCREASED 29 0.0716
61 CHOREOATHETOSIS 48 0.0707
62 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 45 0.0679
63 OBSESSIVE-COMPULSIVE DISORDER 542 0.0675
64 HYPERPROLACTINAEMIA 436 0.0672
65 STEREOTYPY 63 0.0668
66 TRICHOTILLOMANIA 39 0.0666
67 PERSONAL RELATIONSHIP ISSUE 44 0.0658
68 ANTIPSYCHOTIC DRUG LEVEL INCREASED 183 0.0649
69 SOCIAL ANXIETY DISORDER 42 0.0639
70 VICTIM OF CRIME 79 0.0637
71 BLUNTED AFFECT 47 0.0637
72 PSYCHIATRIC DECOMPENSATION 123 0.0629
73 FOETAL DISORDER 51 0.0610
74 COMPULSIONS 40 0.0601
75 CATATONIA 312 0.0594
76 CHOLESTASIS OF PREGNANCY 27 0.0587
77 SEXUAL DYSFUNCTION 676 0.0576
78 IMPULSIVE BEHAVIOUR 207 0.0551
79 SUPPRESSED LACTATION 41 0.0546
80 HALLUCINATION, AUDITORY 846 0.0532
81 PLEUROTHOTONUS 48 0.0531
82 PARKINSONIAN GAIT 32 0.0513
83 DELUSIONAL DISORDER, UNSPECIFIED TYPE 38 0.0508
84 SEDATION 1318 0.0503
85 NEURODEGENERATIVE DISORDER 31 0.0502
86 BLOOD IMMUNOGLOBULIN A INCREASED 27 0.0501
87 LYMPHOCYTE COUNT ABNORMAL 56 0.0497
88 SUSPICIOUSNESS 35 0.0497
89 DYSTONIA 955 0.0492
90 AGITATION NEONATAL 47 0.0490
91 SELECTIVE EATING DISORDER 44 0.0484
92 LOSS OF EMPLOYMENT 143 0.0473
93 EOSINOPHILIC MYOCARDITIS 34 0.0466
94 RESTING TREMOR 30 0.0464
95 SOLILOQUY 40 0.0462
96 SALIVARY HYPERSECRETION 442 0.0441
97 EXTRAPYRAMIDAL DISORDER 1097 0.0441
98 HYPOMANIA 160 0.0435
99 CONSCIOUSNESS FLUCTUATING 45 0.0431
100 TORTICOLLIS 91 0.0429
101 NEPHROGENIC DIABETES INSIPIDUS 49 0.0425
102 EOSINOPHIL COUNT DECREASED 100 0.0420
103 SUBSTANCE DEPENDENCE 28 0.0416
104 PSYCHOTIC DISORDER 1229 0.0416
105 VITAMIN B12 INCREASED 33 0.0414
106 DELUSION 635 0.0408
107 LIBIDO INCREASED 80 0.0394
108 PERSONALITY CHANGE 363 0.0390
109 GESTATIONAL DIABETES 185 0.0388
110 NEGATIVISM 29 0.0382
111 GLOMERULAR FILTRATION RATE INCREASED 31 0.0375
112 MULTIPLE DRUG THERAPY 28 0.0371
113 GAZE PALSY 62 0.0364
114 PSYCHOMOTOR RETARDATION 102 0.0363
115 TONGUE MOVEMENT DISTURBANCE 31 0.0362
116 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 79 0.0353
117 BLOOD PROLACTIN INCREASED 166 0.0352
118 SOCIAL AVOIDANT BEHAVIOUR 202 0.0349
119 ACUTE PSYCHOSIS 86 0.0347
120 MEGACOLON 53 0.0337
121 MUTISM 48 0.0330
122 THERAPEUTIC PRODUCT EFFECT VARIABLE 127 0.0327
123 INAPPROPRIATE AFFECT 50 0.0315
124 DISTURBANCE IN SEXUAL AROUSAL 29 0.0315
125 ELECTRIC SHOCK 27 0.0315
126 BIPOLAR I DISORDER 68 0.0310
127 EMOTIONAL POVERTY 54 0.0308
128 MYOCARDITIS 353 0.0308
129 TROPONIN T INCREASED 39 0.0307
130 ECONOMIC PROBLEM 465 0.0307
131 DYSLIPIDAEMIA 155 0.0305
132 ABULIA 28 0.0303
133 DEPRESSIVE SYMPTOM 105 0.0298
134 PRIAPISM 102 0.0295
135 MANIA 484 0.0294
136 OBSESSIVE THOUGHTS 52 0.0288
137 DACTYLITIS 28 0.0285
138 POSTURE ABNORMAL 92 0.0283
139 MUSCLE RIGIDITY 334 0.0279
140 SUBSTANCE USE DISORDER 88 0.0276
141 PARADOXICAL DRUG REACTION 100 0.0272
142 TONGUE BITING 56 0.0271
143 SEROTONIN SYNDROME 518 0.0269
144 APRAXIA 39 0.0263
145 SUICIDE ATTEMPT 1582 0.0261
146 HYPERPHAGIA 104 0.0261
147 DRUG CLEARANCE DECREASED 34 0.0260
148 MEAN CELL HAEMOGLOBIN DECREASED 47 0.0257
149 SYSTOLIC DYSFUNCTION 27 0.0256
150 HEAD TITUBATION 35 0.0254
151 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 50 0.0253
152 COMA SCALE ABNORMAL 72 0.0248
153 MONOCYTE COUNT INCREASED 90 0.0248
154 NEUTROPHIL COUNT INCREASED 249 0.0243
155 EUPHORIC MOOD 248 0.0242
156 TARDIVE DYSKINESIA 683 0.0242
157 RHEUMATOID FACTOR INCREASED 27 0.0242
158 DRUG LEVEL INCREASED 400 0.0241
159 ELECTROCARDIOGRAM QT PROLONGED 860 0.0239
160 LOGORRHOEA 84 0.0238
161 SUBSTANCE USE 37 0.0237
162 AUTONOMIC NERVOUS SYSTEM IMBALANCE 69 0.0236
163 HYPERREFLEXIA 82 0.0235
164 AFFECTIVE DISORDER 185 0.0235
165 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 120 0.0234
166 FLAT AFFECT 54 0.0233
167 HALLUCINATIONS, MIXED 98 0.0233
168 RECTAL PROLAPSE 28 0.0232
169 DYSKINESIA 937 0.0230
170 INTRUSIVE THOUGHTS 27 0.0229
171 JUVENILE IDIOPATHIC ARTHRITIS 56 0.0229
172 INTENTIONAL SELF-INJURY 460 0.0228
173 PULMONARY VALVE INCOMPETENCE 33 0.0226
174 GALACTORRHOEA 145 0.0226
175 SINUS TACHYCARDIA 319 0.0224
176 OBESITY 357 0.0224
177 PERSONALITY DISORDER 58 0.0221
178 HOMICIDAL IDEATION 88 0.0217
179 BEHAVIOUR DISORDER 117 0.0216
180 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 36 0.0216
181 PARANOIA 371 0.0215
182 MEAN CELL VOLUME DECREASED 33 0.0214
183 WHITE BLOOD CELLS URINE POSITIVE 40 0.0212
184 TRISMUS 109 0.0211
185 STUPOR 67 0.0208
186 SLOW RESPONSE TO STIMULI 27 0.0208
187 HYPERKINESIA 44 0.0207
188 RHINALGIA 57 0.0207
189 APATHY 301 0.0206
190 POTENTIATING DRUG INTERACTION 69 0.0205
191 HOSTILITY 52 0.0204
192 STARING 49 0.0203
193 DISORGANISED SPEECH 37 0.0201
194 BODY MASS INDEX INCREASED 27 0.0200
195 JUDGEMENT IMPAIRED 29 0.0199
196 PERIPHERAL ARTERY THROMBOSIS 28 0.0199
197 HYPOSPADIAS 41 0.0197
198 MENTAL IMPAIRMENT 477 0.0197
199 BRUXISM 106 0.0196
200 ELECTROENCEPHALOGRAM ABNORMAL 62 0.0196
201 BRADYKINESIA 115 0.0195
202 TIC 106 0.0194
203 POISONING DELIBERATE 183 0.0193
204 INSULIN RESISTANCE 40 0.0192
205 SUSPECTED SUICIDE 89 0.0190
206 SOCIAL PROBLEM 78 0.0188
207 ANTICHOLINERGIC SYNDROME 30 0.0188
208 HYPERAMMONAEMIA 94 0.0188
209 RESPIRATORY DEPRESSION 230 0.0187
210 ILLUSION 31 0.0187
211 SELF-INJURIOUS IDEATION 78 0.0186
212 INHIBITORY DRUG INTERACTION 29 0.0183
213 PSYCHIATRIC SYMPTOM 135 0.0183
214 AUTISM SPECTRUM DISORDER 100 0.0181
215 BIPOLAR DISORDER 196 0.0180
216 TROPONIN I INCREASED 30 0.0180
217 INTELLECTUAL DISABILITY 27 0.0178
218 HEAT STROKE 27 0.0177
219 EXCESSIVE EYE BLINKING 26 0.0176
220 VENTRICULAR SEPTAL DEFECT 100 0.0174
221 BRADYPHRENIA 114 0.0174
222 TREATMENT NONCOMPLIANCE 948 0.0173
223 PSYCHOMOTOR SKILLS IMPAIRED 45 0.0172
224 PSYCHOMOTOR HYPERACTIVITY 285 0.0172
225 DROOLING 118 0.0171
226 NARCOLEPSY 32 0.0169
227 BODY TEMPERATURE ABNORMAL 31 0.0168
228 CLONUS 46 0.0168
229 CLEFT PALATE 32 0.0165
230 ALCOHOL ABUSE 44 0.0164
231 HYPOTHERMIA 166 0.0164
232 RESTLESSNESS 600 0.0164
233 INCREASED APPETITE 312 0.0163
234 TROPONIN INCREASED 122 0.0160
235 AGGRESSION 797 0.0159
236 HYPERNATRAEMIA 79 0.0158
237 SUICIDAL IDEATION 1449 0.0158
238 MATERNAL EXPOSURE DURING BREAST FEEDING 64 0.0158
239 CHOREA 27 0.0157
240 SLOW SPEECH 38 0.0156
241 BLOOD PHOSPHORUS DECREASED 57 0.0156
242 FEAR OF DEATH 35 0.0156
243 AKINESIA 32 0.0154
244 BLOOD CREATINE PHOSPHOKINASE INCREASED 440 0.0153
245 SUBSTANCE ABUSE 123 0.0151
246 INTERVERTEBRAL DISCITIS 28 0.0148
247 BICYTOPENIA 29 0.0148
248 REFUSAL OF TREATMENT BY PATIENT 96 0.0147
249 POLYDIPSIA 58 0.0147
250 MUSCLE CONTRACTIONS INVOLUNTARY 51 0.0145
251 DRUG MONITORING PROCEDURE NOT PERFORMED 26 0.0145
252 DRUG INTERACTION 2286 0.0144
253 PHYSICAL ASSAULT 30 0.0143
254 LANGUAGE DISORDER 31 0.0143
255 INFARCTION 98 0.0143
256 JOINT NOISE 28 0.0142
257 HYPERTONIA 81 0.0141
258 WRONG PATIENT RECEIVED PRODUCT 41 0.0140
259 MYOPIA 33 0.0138
260 TACHYPHRENIA 48 0.0138
261 DRUG LEVEL ABOVE THERAPEUTIC 63 0.0137
262 SUICIDAL BEHAVIOUR 56 0.0134
263 AFFECT LABILITY 129 0.0134
264 ENURESIS 54 0.0134
265 MAJOR DEPRESSION 97 0.0133
266 THINKING ABNORMAL 246 0.0132
267 MENTAL DISORDER 573 0.0132
268 SOPOR 170 0.0128
269 TENSION 78 0.0128
270 DISTRIBUTIVE SHOCK 29 0.0128
271 SLEEP DEFICIT 27 0.0128
272 INSURANCE ISSUE 195 0.0127
273 MYOCLONUS 152 0.0127
274 INTENTIONAL OVERDOSE 814 0.0127
275 NEUTROPHILIA 72 0.0126
276 BLEPHAROSPASM 79 0.0125
277 LONG QT SYNDROME 30 0.0125
278 LEFT VENTRICULAR DYSFUNCTION 83 0.0124
279 ABNORMAL BEHAVIOUR 486 0.0123
280 AGITATION 894 0.0122
281 HYPERTONIC BLADDER 35 0.0121
282 SUDDEN CARDIAC DEATH 41 0.0120
283 HALLUCINATION, VISUAL 253 0.0120
284 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 123 0.0120
285 HYPERTHERMIA 89 0.0116
286 EATING DISORDER 246 0.0115
287 ANHEDONIA 303 0.0115
288 TEARFULNESS 49 0.0114
289 BUNDLE BRANCH BLOCK RIGHT 52 0.0113
290 RED CELL DISTRIBUTION WIDTH INCREASED 47 0.0113
291 ANORGASMIA 30 0.0110
292 SYMPTOM RECURRENCE 66 0.0110
293 EYE MOVEMENT DISORDER 75 0.0109
294 NEGATIVE THOUGHTS 32 0.0109
295 LEUKAEMIA 103 0.0109
296 HIGH DENSITY LIPOPROTEIN DECREASED 36 0.0108
297 DIABETES INSIPIDUS 26 0.0108
298 DELIRIUM 374 0.0108
299 HICCUPS 87 0.0106
300 DISABILITY 209 0.0106
301 LIVE BIRTH 88 0.0105
302 DYSPHORIA 53 0.0105
303 FOOD CRAVING 55 0.0104
304 DRUG ABUSE 869 0.0104
305 RESTLESS LEGS SYNDROME 188 0.0103
306 THERAPY PARTIAL RESPONDER 161 0.0103
307 POST-TRAUMATIC STRESS DISORDER 69 0.0103
308 INABILITY TO AFFORD MEDICATION 102 0.0103
309 COMPLETED SUICIDE 854 0.0102
310 PRESCRIBED OVERDOSE 196 0.0101
311 VITAMIN B12 DECREASED 29 0.0101
312 ELECTRIC SHOCK SENSATION 28 0.0100
313 LOSS OF LIBIDO 89 0.0099
314 DEPRESSED MOOD 523 0.0099
315 VITAMIN B12 DEFICIENCY 40 0.0099
316 IRRITABILITY 592 0.0098
317 ATAXIA 116 0.0098
318 MIOSIS 78 0.0097
319 TORSADE DE POINTES 76 0.0097
320 WEIGHT INCREASED 2162 0.0096
321 SOMNAMBULISM 63 0.0096
322 ORTHOSTATIC HYPOTENSION 165 0.0095
323 TOXIC ENCEPHALOPATHY 48 0.0095
324 ALTERED STATE OF CONSCIOUSNESS 205 0.0095
325 RHABDOMYOLYSIS 394 0.0094
326 SCREAMING 60 0.0094
327 POLYURIA 77 0.0094
328 HYPERTRIGLYCERIDAEMIA 55 0.0094
329 LEUKOCYTOSIS 169 0.0093
330 MEDICATION ERROR 518 0.0093
331 AMYLASE INCREASED 34 0.0092
332 LEUKOPENIA 459 0.0092
333 PRODUCT USE IN UNAPPROVED INDICATION 2270 0.0091
334 GRANULOCYTOPENIA 52 0.0091
335 OVERWEIGHT 49 0.0091
336 URINARY INCONTINENCE 269 0.0091
337 ABORTION 26 0.0089
338 DECREASED INTEREST 52 0.0088
339 BLOOD PRESSURE SYSTOLIC DECREASED 40 0.0088
340 ELECTROCARDIOGRAM ABNORMAL 69 0.0088
341 MYDRIASIS 112 0.0087
342 BUNDLE BRANCH BLOCK LEFT 37 0.0087
343 COORDINATION ABNORMAL 121 0.0087
344 PRESCRIBED UNDERDOSE 173 0.0087
345 DYSPHEMIA 38 0.0087
346 COGNITIVE DISORDER 402 0.0086
347 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 52 0.0085
348 BREAST ENLARGEMENT 28 0.0085
349 SELF-MEDICATION 35 0.0085
350 NYSTAGMUS 45 0.0085
351 TOXICITY TO VARIOUS AGENTS 1429 0.0085
352 DYSARTHRIA 318 0.0084
353 DEPRESSED LEVEL OF CONSCIOUSNESS 332 0.0084
354 LOW BIRTH WEIGHT BABY 66 0.0083
355 HYPOKINESIA 120 0.0083
356 FOETAL EXPOSURE DURING PREGNANCY 667 0.0082
357 EXPOSURE DURING BREAST FEEDING 27 0.0081
358 LYMPHOCYTE COUNT DECREASED 144 0.0081
359 COMMUNICATION DISORDER 31 0.0081
360 EXPOSURE VIA BREAST MILK 32 0.0080
361 THROAT CLEARING 30 0.0080
362 DRUG LEVEL BELOW THERAPEUTIC 44 0.0080
363 DRUG USE DISORDER 67 0.0080
364 DISTURBANCE IN ATTENTION 422 0.0078
365 BLOOD TRIGLYCERIDES INCREASED 138 0.0078
366 PREMATURE LABOUR 44 0.0078
367 PREMATURE BABY 231 0.0077
368 SMALL FOR DATES BABY 38 0.0076
369 COMA 363 0.0076
370 STRESS CARDIOMYOPATHY 44 0.0076
371 CAESAREAN SECTION 88 0.0076
372 ARTERIOSCLEROSIS CORONARY ARTERY 50 0.0075
373 C-REACTIVE PROTEIN INCREASED 274 0.0075
374 ATRIAL SEPTAL DEFECT 63 0.0075
375 PNEUMONIA ASPIRATION 187 0.0075
376 PRODUCT PRESCRIBING ERROR 178 0.0075
377 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 530 0.0074
378 BRAIN INJURY 74 0.0074
379 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 50 0.0073
380 DISSOCIATION 56 0.0073
381 CONGESTIVE CARDIOMYOPATHY 30 0.0072
382 GENERALISED TONIC-CLONIC SEIZURE 119 0.0072
383 SLEEP APNOEA SYNDROME 137 0.0072
384 ANGER 242 0.0071
385 SNORING 27 0.0071
386 DRUG RESISTANCE 183 0.0071
387 TREMOR 1182 0.0071
388 TACHYCARDIA 631 0.0071
389 DEMYELINATION 29 0.0071
390 ABNORMAL WEIGHT GAIN 87 0.0070
391 SINUS BRADYCARDIA 68 0.0070
392 LEFT VENTRICULAR HYPERTROPHY 30 0.0070
393 CARDIO-RESPIRATORY ARREST 292 0.0070
394 DISORIENTATION 275 0.0069
395 HALLUCINATION 521 0.0069
396 AMENORRHOEA 121 0.0069
397 URINARY RETENTION 230 0.0069
398 PRODUCT ADMINISTRATION INTERRUPTED 54 0.0069
399 MATERNAL EXPOSURE DURING PREGNANCY 613 0.0069
400 CONCUSSION 53 0.0068
401 HYPERCHOLESTEROLAEMIA 66 0.0068
402 WHITE BLOOD CELL COUNT INCREASED 262 0.0068
403 HAEMODYNAMIC INSTABILITY 52 0.0068
404 MUSCLE TWITCHING 157 0.0068
405 TYPE 2 DIABETES MELLITUS 229 0.0068
406 SOMNOLENCE 1363 0.0068
407 TRICUSPID VALVE INCOMPETENCE 53 0.0067
408 ATTENTION DEFICIT HYPERACTIVITY DISORDER 28 0.0066
409 REBOUND EFFECT 75 0.0066
410 CARDIOMYOPATHY 98 0.0066
411 EXPOSURE DURING PREGNANCY 407 0.0065
412 PHOTOPSIA 41 0.0065
413 NORMAL NEWBORN 35 0.0064
414 FOETAL GROWTH RESTRICTION 39 0.0064
415 BLOOD URIC ACID INCREASED 37 0.0064
416 PREMATURE DELIVERY 102 0.0064
417 FAECALOMA 35 0.0064
418 HYPERVENTILATION 37 0.0064
419 HAEMOGLOBIN INCREASED 29 0.0064
420 ANXIETY 1796 0.0063
421 PETIT MAL EPILEPSY 32 0.0063
422 GLUCOSE TOLERANCE IMPAIRED 37 0.0063
423 ASPHYXIA 51 0.0062
424 INCONTINENCE 66 0.0062
425 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27 0.0062
426 HYPERSOMNIA 178 0.0062
427 CHOLECYSTITIS ACUTE 35 0.0062
428 NICOTINE DEPENDENCE 48 0.0062
429 PRE-ECLAMPSIA 29 0.0061
430 WITHDRAWAL SYNDROME 256 0.0061
431 NEUTROPHIL COUNT DECREASED 248 0.0061
432 TREATMENT FAILURE 504 0.0061
433 COLITIS ISCHAEMIC 41 0.0061
434 DIABETIC KETOACIDOSIS 145 0.0060
435 HYPOTONIA 60 0.0060
436 HEPATIC CYTOLYSIS 76 0.0060
437 SUPRAVENTRICULAR TACHYCARDIA 57 0.0059
438 INITIAL INSOMNIA 61 0.0059
439 HYPERLIPIDAEMIA 71 0.0059
440 EOSINOPHILIA 104 0.0059
441 BRAIN FOG 93 0.0059
442 PRODUCT AVAILABILITY ISSUE 135 0.0059
443 THERAPY CHANGE 58 0.0059
444 ANAL INCONTINENCE 53 0.0059
445 ERECTILE DYSFUNCTION 151 0.0059
446 DIABETES MELLITUS 448 0.0059
447 MOVEMENT DISORDER 187 0.0058
448 POISONING 73 0.0058
449 STATUS EPILEPTICUS 65 0.0057
450 PARTIAL SEIZURES 30 0.0057
451 BLOOD ALBUMIN DECREASED 45 0.0057
452 MITRAL VALVE INCOMPETENCE 64 0.0056
453 CONDITION AGGRAVATED 1712 0.0056
454 MOOD SWINGS 179 0.0056
455 ATELECTASIS 54 0.0056
456 SLEEP DISORDER 394 0.0056
457 FEELING OF DESPAIR 26 0.0056
458 TONSILLITIS 29 0.0056
459 VITAMIN D DEFICIENCY 54 0.0055
460 MOOD ALTERED 150 0.0055
461 POOR QUALITY SLEEP 118 0.0055
462 ABORTION SPONTANEOUS 219 0.0055
463 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 299 0.0054
464 URINE ODOUR ABNORMAL 32 0.0054
465 ENCEPHALOPATHY 133 0.0054
466 SEIZURE 621 0.0054
467 DEPRESSION 1220 0.0054
468 APNOEA 41 0.0053
469 CARDIAC FAILURE ACUTE 35 0.0052
470 SUDDEN DEATH 55 0.0052
471 SPEECH DISORDER 272 0.0052
472 LOW DENSITY LIPOPROTEIN INCREASED 40 0.0052
473 THERAPY NON-RESPONDER 232 0.0052
474 UNRESPONSIVE TO STIMULI 133 0.0051
475 SARS-COV-2 TEST POSITIVE 68 0.0051
476 VERTIGO 313 0.0051
477 CONFUSIONAL STATE 828 0.0051
478 RESPIRATORY ARREST 141 0.0051
479 TENDERNESS 53 0.0051
480 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 244 0.0051
481 TACHYPNOEA 69 0.0051
482 INTRACRANIAL PRESSURE INCREASED 28 0.0050
483 AGRANULOCYTOSIS 93 0.0050
484 PERICARDITIS 84 0.0050
485 HYPERGLYCAEMIA 182 0.0050
486 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 128 0.0050
487 MUSCULOSKELETAL STIFFNESS 435 0.0050
488 MENTAL STATUS CHANGES 137 0.0049
489 INJURY 346 0.0049
490 IMPAIRED GASTRIC EMPTYING 67 0.0049
491 ILEUS 61 0.0049
492 RED BLOOD CELL SEDIMENTATION RATE INCREASED 54 0.0049
493 PANCREATITIS ACUTE 109 0.0048
494 DRUG LEVEL DECREASED 49 0.0048
495 SLUGGISHNESS 49 0.0048
496 NEUTROPENIA 648 0.0048
497 CRYING 173 0.0048
498 BLOOD PRESSURE DIASTOLIC DECREASED 35 0.0047
499 PULMONARY CONGESTION 62 0.0047
500 PLATELET COUNT INCREASED 61 0.0047
501 APPETITE DISORDER 31 0.0047
502 THERAPY CESSATION 240 0.0047
503 FEAR 123 0.0046
504 INSOMNIA 1214 0.0046
505 TEMPERATURE INTOLERANCE 47 0.0046
506 EPILEPSY 139 0.0045
507 THERAPEUTIC RESPONSE DECREASED 275 0.0045
508 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 40 0.0045
509 INTENTIONAL PRODUCT MISUSE 396 0.0045
510 RENAL TUBULAR NECROSIS 44 0.0045
511 TYPE 1 DIABETES MELLITUS 27 0.0045
512 ENCEPHALITIS 31 0.0045
513 ASPIRATION 49 0.0045
514 LETHARGY 257 0.0045
515 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 32 0.0045
516 FACIAL PARALYSIS 38 0.0045
517 MUSCLE DISORDER 36 0.0044
518 ENERGY INCREASED 26 0.0044
519 HEPATIC STEATOSIS 82 0.0044
520 BRADYCARDIA 233 0.0044
521 CARDIOGENIC SHOCK 63 0.0044
522 EJECTION FRACTION DECREASED 68 0.0044
523 BODY TEMPERATURE INCREASED 89 0.0044
524 OVERDOSE 940 0.0044
525 HYPOTHYROIDISM 139 0.0043
526 DISEASE RECURRENCE 207 0.0043
527 CEREBRAL DISORDER 32 0.0043
528 ACIDOSIS 33 0.0043
529 IMPAIRED QUALITY OF LIFE 62 0.0043
530 CARDIOMEGALY 53 0.0043
531 DRUG EFFECT LESS THAN EXPECTED 63 0.0042
532 HEPATOMEGALY 41 0.0042
533 NIGHTMARE 144 0.0042
534 DEMENTIA 116 0.0041
535 ABORTION INDUCED 39 0.0041
536 HAEMATOCRIT DECREASED 82 0.0041
537 HAEMOLYTIC ANAEMIA 37 0.0041
538 ADRENAL INSUFFICIENCY 49 0.0040
539 RED BLOOD CELL COUNT DECREASED 115 0.0040
540 BLOOD THYROID STIMULATING HORMONE INCREASED 37 0.0040
541 GYNAECOMASTIA 123 0.0040
542 FULL BLOOD COUNT ABNORMAL 42 0.0040
543 AMNESIA 258 0.0040
544 EOSINOPHIL COUNT INCREASED 33 0.0040
545 BLOOD CHOLESTEROL INCREASED 184 0.0039
546 HYPERHIDROSIS 507 0.0039
547 MATERNAL DRUGS AFFECTING FOETUS 30 0.0039
548 SPINAL DISORDER 37 0.0039
549 BLOOD UREA INCREASED 65 0.0039
550 HYPONATRAEMIA 218 0.0039
551 TONGUE DISORDER 28 0.0039
552 BLOOD ALKALINE PHOSPHATASE INCREASED 96 0.0039
553 HYPERTENSIVE CRISIS 43 0.0039
554 CARDIAC ARREST 319 0.0039
555 UNDERDOSE 282 0.0039
556 EMOTIONAL DISORDER 118 0.0038
557 EMOTIONAL DISTRESS 462 0.0038
558 CARDIOTOXICITY 34 0.0038
559 ACUTE RESPIRATORY DISTRESS SYNDROME 67 0.0038
560 LIPASE INCREASED 29 0.0038
561 JOINT DISLOCATION 40 0.0038
562 PANIC ATTACK 137 0.0038
563 HEPATIC FUNCTION ABNORMAL 140 0.0037
564 DYSPHAGIA 354 0.0037
565 DECREASED ACTIVITY 40 0.0037
566 BLOOD TEST ABNORMAL 52 0.0037
567 PHOTOSENSITIVITY REACTION 61 0.0037
568 APHASIA 111 0.0037
569 METABOLIC ACIDOSIS 117 0.0037
570 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 30 0.0036
571 LIVER FUNCTION TEST ABNORMAL 105 0.0036
572 HEPATOCELLULAR INJURY 51 0.0036
573 CIRCULATORY COLLAPSE 61 0.0036
574 INTESTINAL PERFORATION 40 0.0036
575 SENSATION OF FOREIGN BODY 30 0.0036
576 TOXIC EPIDERMAL NECROLYSIS 54 0.0036
577 DRUG SCREEN POSITIVE 28 0.0035
578 PULMONARY EMBOLISM 336 0.0035
579 WHITE BLOOD CELL COUNT DECREASED 381 0.0035
580 GLYCOSYLATED HAEMOGLOBIN INCREASED 88 0.0035
581 ADVERSE DRUG REACTION 313 0.0035
582 VENTRICULAR TACHYCARDIA 57 0.0034
583 FEEDING DISORDER 70 0.0034
584 PRODUCT PRESCRIBING ISSUE 75 0.0034
585 MYOCARDIAL ISCHAEMIA 39 0.0034
586 DIZZINESS POSTURAL 33 0.0034
587 PREGNANCY 68 0.0034
588 MUSCLE TIGHTNESS 55 0.0034
589 HOSPITALISATION 521 0.0034
590 HYPOTENSION 680 0.0034
591 LOSS OF CONSCIOUSNESS 434 0.0034
592 LOWER RESPIRATORY TRACT INFECTION 154 0.0034
593 MENSTRUAL DISORDER 28 0.0034
594 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 99 0.0034
595 OFF LABEL USE 2952 0.0034
596 PRODUCT ADMINISTRATION ERROR 68 0.0034
597 DRUG INEFFECTIVE 4421 0.0034
598 ACUTE KIDNEY INJURY 513 0.0033
599 ACCIDENT 40 0.0033
600 LIGAMENT SPRAIN 33 0.0033
601 GLOMERULAR FILTRATION RATE DECREASED 41 0.0033
602 BRAIN OEDEMA 42 0.0033
603 ALANINE AMINOTRANSFERASE INCREASED 204 0.0033
604 OXYGEN SATURATION DECREASED 186 0.0033
605 THIRST 59 0.0033
606 CONSTIPATION 717 0.0033
607 PARALYSIS 47 0.0033
608 HYPOPHAGIA 83 0.0032
609 PRODUCT USE ISSUE 610 0.0032
610 TRANSAMINASES INCREASED 72 0.0032
611 HUNGER 45 0.0032
612 ACUTE RESPIRATORY FAILURE 62 0.0032
613 DYSSTASIA 94 0.0032
614 DYSURIA 118 0.0032
615 ARRHYTHMIA 151 0.0032
616 DRY MOUTH 258 0.0032
617 MIDDLE INSOMNIA 59 0.0032
618 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70 0.0032
619 RESPIRATORY RATE INCREASED 28 0.0032
620 IRON DEFICIENCY ANAEMIA 29 0.0031
621 QUALITY OF LIFE DECREASED 42 0.0031
622 BLOOD PRESSURE FLUCTUATION 75 0.0031
623 BALANCE DISORDER 270 0.0031
624 BEDRIDDEN 41 0.0031
625 HEAVY MENSTRUAL BLEEDING 28 0.0031
626 ERYTHEMA MULTIFORME 29 0.0031
627 STEVENS-JOHNSON SYNDROME 69 0.0031
628 ELECTROLYTE IMBALANCE 36 0.0031
629 HEAD INJURY 98 0.0031
630 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
631 MEMORY IMPAIRMENT 418 0.0030
632 SCRATCH 32 0.0030
633 ISCHAEMIC STROKE 54 0.0030
634 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 544 0.0030
635 CARDIAC MURMUR 26 0.0030
636 ACUTE HEPATIC FAILURE 41 0.0030
637 OROPHARYNGEAL DISCOMFORT 27 0.0030
638 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 51 0.0030
639 GAIT DISTURBANCE 567 0.0030
640 THROMBOCYTOPENIA 330 0.0029
641 SYNCOPE 295 0.0029
642 BLOOD GLUCOSE INCREASED 550 0.0029
643 BLOOD SODIUM DECREASED 55 0.0029
644 HYPERTENSION 617 0.0029
645 CHRONIC KIDNEY DISEASE 221 0.0029
646 END STAGE RENAL DISEASE 53 0.0029
647 MICTURITION URGENCY 33 0.0029
648 CHOKING 56 0.0029
649 LIVER INJURY 70 0.0028
650 MUCOSAL INFLAMMATION 74 0.0028
651 SEASONAL ALLERGY 40 0.0028
652 PHOTOPHOBIA 53 0.0028
653 SPLENOMEGALY 33 0.0028
654 NERVOUSNESS 147 0.0028
655 VISION BLURRED 386 0.0028
656 GASTROENTERITIS 41 0.0028
657 HEART RATE INCREASED 278 0.0028
658 DRUG-INDUCED LIVER INJURY 88 0.0028
659 MULTIPLE FRACTURES 46 0.0028
660 PHARYNGEAL SWELLING 27 0.0028
661 PERITONITIS 57 0.0027
662 PRODUCT SUBSTITUTION ISSUE 158 0.0027
663 PULMONARY OEDEMA 122 0.0027
664 CONTRAINDICATED PRODUCT ADMINISTERED 82 0.0027
665 CELLULITIS 136 0.0027
666 LYMPHOPENIA 38 0.0027
667 DRUG INTOLERANCE 258 0.0027
668 GENERALISED OEDEMA 33 0.0027
669 PHARYNGITIS 33 0.0027
670 ULCER 42 0.0026
671 DENTAL CARIES 29 0.0026
672 WEIGHT FLUCTUATION 27 0.0026
673 PRODUCT DOSE OMISSION IN ERROR 73 0.0026
674 DRUG WITHDRAWAL SYNDROME NEONATAL 38 0.0026
675 PERICARDIAL EFFUSION 59 0.0025
676 FIBROMYALGIA 62 0.0025
677 PALLOR 69 0.0025
678 ASPARTATE AMINOTRANSFERASE INCREASED 134 0.0025
679 EAR PAIN 49 0.0025
680 SINUS CONGESTION 34 0.0025
681 HYPOKALAEMIA 116 0.0025
682 RESPIRATORY DISTRESS 69 0.0025
683 MUSCULAR WEAKNESS 284 0.0025
684 SWOLLEN TONGUE 78 0.0025
685 JOINT STIFFNESS 65 0.0025
686 INTERVERTEBRAL DISC PROTRUSION 54 0.0025
687 ANKLE FRACTURE 38 0.0025
688 HYPOGLYCAEMIA 119 0.0025
689 INTESTINAL OBSTRUCTION 92 0.0024
690 ACCIDENTAL OVERDOSE 89 0.0024
691 CYANOSIS 38 0.0024
692 PRESYNCOPE 58 0.0024
693 TUBULOINTERSTITIAL NEPHRITIS 44 0.0023
694 HEART RATE DECREASED 82 0.0023
695 PANCREATITIS 123 0.0023
696 RESPIRATORY FAILURE 169 0.0023
697 DIPLOPIA 60 0.0023
698 NERVOUS SYSTEM DISORDER 72 0.0023
699 SHOCK 53 0.0023
700 IMPAIRED WORK ABILITY 49 0.0023
701 NEUROTOXICITY 40 0.0023
702 COAGULOPATHY 38 0.0023
703 ANGINA PECTORIS 65 0.0023
704 DEEP VEIN THROMBOSIS 147 0.0023
705 POLLAKIURIA 94 0.0023
706 CHEST PAIN 416 0.0022
707 HYPOXIA 79 0.0022
708 ADVERSE EVENT 206 0.0022
709 ABNORMAL DREAMS 61 0.0022
710 FEELING JITTERY 42 0.0022
711 FALL 733 0.0022
712 PLATELET COUNT DECREASED 234 0.0022
713 DRY EYE 109 0.0022
714 CENTRAL NERVOUS SYSTEM LESION 30 0.0022
715 STAPHYLOCOCCAL INFECTION 72 0.0022
716 DIZZINESS 1080 0.0022
717 VOMITING 1012 0.0022
718 HEAD DISCOMFORT 38 0.0021
719 RENAL IMPAIRMENT 180 0.0021
720 MENORRHAGIA 42 0.0021
721 FEELING ABNORMAL 511 0.0021
722 MYALGIA 362 0.0021
723 DEHYDRATION 284 0.0021
724 PERIPHERAL COLDNESS 29 0.0021
725 LACTIC ACIDOSIS 68 0.0021
726 IRRITABLE BOWEL SYNDROME 45 0.0021
727 BLOOD CREATININE INCREASED 137 0.0021
728 NO ADVERSE EVENT 380 0.0021
729 MENSTRUATION IRREGULAR 56 0.0021
730 MULTIPLE ORGAN DYSFUNCTION SYNDROME 59 0.0021
731 ROAD TRAFFIC ACCIDENT 86 0.0021
732 SYNOVITIS 37 0.0020
733 ORAL CANDIDIASIS 27 0.0020
734 DYSPEPSIA 199 0.0020
735 MIGRAINE 193 0.0020
736 SCIATICA 32 0.0020
737 HYPERKALAEMIA 70 0.0020
738 FATIGUE 1545 0.0020
739 HAEMATEMESIS 50 0.0020
740 CLOSTRIDIUM DIFFICILE INFECTION 43 0.0020
741 MUSCLE SPASMS 361 0.0020
742 FACE OEDEMA 33 0.0020
743 URINARY TRACT INFECTION 333 0.0020
744 VISUAL IMPAIRMENT 241 0.0019
745 DRUG EFFECT INCOMPLETE 70 0.0019
746 ILLNESS 198 0.0019
747 NECK PAIN 107 0.0019
748 BLOOD PRESSURE ABNORMAL 38 0.0019
749 PANCYTOPENIA 106 0.0019
750 BLOOD PRESSURE DECREASED 126 0.0019
751 PYREXIA 656 0.0019
752 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
753 NEUROPATHY PERIPHERAL 180 0.0019
754 ABSCESS 30 0.0019
755 TOOTHACHE 34 0.0019
756 LIMB DISCOMFORT 58 0.0019
757 PULMONARY HYPERTENSION 39 0.0019
758 OEDEMA PERIPHERAL 228 0.0019
759 MALAISE 819 0.0019
760 LIVER FUNCTION TEST INCREASED 40 0.0019
761 CHOLELITHIASIS 61 0.0019
762 HEART RATE IRREGULAR 42 0.0019
763 DYSPHONIA 108 0.0018
764 PALPITATIONS 216 0.0018
765 DISCOMFORT 112 0.0018
766 THERAPY INTERRUPTED 131 0.0018
767 CONJUNCTIVITIS 34 0.0018
768 ASTHMA 207 0.0018
769 DRUG DEPENDENCE 294 0.0018
770 CHOLESTASIS 35 0.0018
771 SKIN HAEMORRHAGE 27 0.0018
772 PULMONARY MASS 27 0.0018
773 ANGIOEDEMA 80 0.0018
774 ANOSMIA 26 0.0018
775 SEPSIS 200 0.0018
776 TOOTH LOSS 37 0.0018
777 OROPHARYNGEAL PAIN 165 0.0018
778 HAEMOGLOBIN DECREASED 183 0.0018
779 BRONCHITIS 131 0.0018
780 NASAL CONGESTION 104 0.0018
781 HEADACHE 1106 0.0018
782 NAUSEA 1384 0.0017
783 SENSORY DISTURBANCE 28 0.0017
784 BLOOD PRESSURE SYSTOLIC INCREASED 34 0.0017
785 RESPIRATORY TRACT INFECTION 45 0.0017
786 WEIGHT DECREASED 482 0.0017
787 INTENTIONAL PRODUCT USE ISSUE 151 0.0017
788 DRUG WITHDRAWAL SYNDROME 151 0.0017
789 PERIPHERAL SWELLING 265 0.0017
790 BLOOD BILIRUBIN INCREASED 46 0.0017
791 RHINORRHOEA 110 0.0017
792 PSORIATIC ARTHROPATHY 69 0.0017
793 PRODUCT DISPENSING ERROR 37 0.0017
794 ASTHENIA 635 0.0017
795 OSTEOPOROSIS 69 0.0017
796 JAUNDICE 45 0.0017
797 DECREASED APPETITE 388 0.0017
798 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 86 0.0016
799 RENAL FAILURE 217 0.0016
800 VISUAL ACUITY REDUCED 54 0.0016
801 ALOPECIA 319 0.0016
802 FEELING HOT 99 0.0016
803 MOBILITY DECREASED 116 0.0016
804 EYE PAIN 91 0.0016
805 GASTROENTERITIS VIRAL 29 0.0016
806 PRODUCT DOSE OMISSION ISSUE 472 0.0016
807 CANDIDA INFECTION 27 0.0016
808 BLOOD POTASSIUM DECREASED 48 0.0016
809 BLOOD PRESSURE INCREASED 244 0.0016
810 ABDOMINAL DISTENSION 166 0.0016
811 COLD SWEAT 28 0.0016
812 BLOOD GLUCOSE DECREASED 76 0.0016
813 DRUG ERUPTION 28 0.0016
814 RASH MACULO-PAPULAR 35 0.0016
815 TINNITUS 72 0.0016
816 HEPATITIS 40 0.0016
817 GASTROOESOPHAGEAL REFLUX DISEASE 125 0.0016
818 ABDOMINAL PAIN 359 0.0015
819 THERAPEUTIC PRODUCT EFFECT DECREASED 69 0.0015
820 THROAT IRRITATION 69 0.0015
821 HYPOCALCAEMIA 29 0.0015
822 FOOT FRACTURE 29 0.0015
823 COVID-19 268 0.0015
824 GASTROINTESTINAL DISORDER 136 0.0015
825 BLOOD GLUCOSE ABNORMAL 28 0.0015
826 PNEUMONIA 490 0.0015
827 THERAPEUTIC RESPONSE SHORTENED 50 0.0015
828 HERNIA 29 0.0015
829 CHEST DISCOMFORT 152 0.0015
830 PAIN IN JAW 42 0.0015
831 PAIN 910 0.0015
832 RENAL INJURY 44 0.0015
833 GENERAL PHYSICAL HEALTH DETERIORATION 170 0.0015
834 LYMPHADENOPATHY 52 0.0015
835 WHEEZING 87 0.0015
836 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 297 0.0015
837 HEPATIC FAILURE 44 0.0015
838 RIB FRACTURE 30 0.0015
839 DYSPNOEA 820 0.0014
840 AGEUSIA 36 0.0014
841 EYE DISORDER 47 0.0014
842 TASTE DISORDER 29 0.0014
843 KIDNEY INFECTION 28 0.0014
844 SNEEZING 32 0.0014
845 BACK PAIN 330 0.0014
846 NEOPLASM PROGRESSION 49 0.0014
847 HEPATIC ENZYME INCREASED 96 0.0014
848 GASTRITIS 37 0.0014
849 CONTUSION 135 0.0014
850 RENAL DISORDER 65 0.0014
851 PRODUCT DOSE OMISSION 91 0.0014
852 BACTERIAL INFECTION 26 0.0014
853 TRANSIENT ISCHAEMIC ATTACK 47 0.0014
854 CEREBRAL INFARCTION 34 0.0014
855 INFLUENZA 154 0.0014
856 CARDIAC DISORDER 129 0.0014
857 INFLAMMATION 71 0.0014
858 INTENTIONAL DOSE OMISSION 39 0.0014
859 FEELING COLD 38 0.0014
860 RETCHING 29 0.0014
861 HYPOAESTHESIA 203 0.0014
862 HAEMATOMA 35 0.0013
863 SKIN DISORDER 45 0.0013
864 PARAESTHESIA 212 0.0013
865 OEDEMA 73 0.0013
866 ERUCTATION 26 0.0013
867 THERAPEUTIC RESPONSE UNEXPECTED 60 0.0013
868 EPISTAXIS 100 0.0013
869 DEPENDENCE 73 0.0013
870 SWELLING FACE 86 0.0013
871 ACTIVITIES OF DAILY LIVING IMPAIRED 26 0.0013
872 RASH GENERALISED 34 0.0013
873 ATRIAL FIBRILLATION 127 0.0013
874 ANAPHYLACTIC REACTION 72 0.0013
875 INFLUENZA LIKE ILLNESS 106 0.0013
876 DIARRHOEA 829 0.0013
877 INCORRECT DOSE ADMINISTERED 293 0.0013
878 ARTHRALGIA 530 0.0013
879 SURGERY 74 0.0013
880 THROAT TIGHTNESS 34 0.0013
881 GAIT INABILITY 42 0.0013
882 INFECTION 180 0.0012
883 ANAEMIA 237 0.0012
884 BURNING SENSATION 86 0.0012
885 ABDOMINAL PAIN UPPER 252 0.0012
886 SKIN DISCOLOURATION 56 0.0012
887 MULTIPLE SCLEROSIS 58 0.0012
888 CONVULSION 69 0.0012
889 BLINDNESS 49 0.0012
890 CHILLS 140 0.0012
891 WOUND 33 0.0012
892 OSTEOARTHRITIS 50 0.0012
893 DERMATITIS ATOPIC 62 0.0012
894 LIP SWELLING 39 0.0012
895 ECZEMA 61 0.0012
896 EAR INFECTION 31 0.0012
897 LACRIMATION INCREASED 35 0.0012
898 LIMB INJURY 31 0.0011
899 ABDOMINAL DISCOMFORT 190 0.0011
900 PRODUCTIVE COUGH 54 0.0011
901 CYSTITIS 36 0.0011
902 VAGINAL HAEMORRHAGE 49 0.0011
903 SEPTIC SHOCK 49 0.0011
904 JOINT SWELLING 134 0.0011
905 THROMBOSIS 89 0.0011
906 COUGH 310 0.0011
907 UPPER RESPIRATORY TRACT INFECTION 51 0.0011
908 DISEASE PROGRESSION 130 0.0011
909 OCULAR HYPERAEMIA 52 0.0011
910 RASH 476 0.0011
911 DRUG EXPOSURE DURING PREGNANCY 37 0.0011
912 INTERNATIONAL NORMALISED RATIO INCREASED 31 0.0011
913 NIGHT SWEATS 35 0.0011
914 CARDIAC FAILURE 87 0.0011
915 PAIN IN EXTREMITY 319 0.0011
916 GASTRIC DISORDER 37 0.0011
917 FLATULENCE 61 0.0011
918 BONE PAIN 63 0.0011
919 SKIN LESION 29 0.0011
920 VIRAL INFECTION 35 0.0011
921 ARTHRITIS 81 0.0010
922 NEPHROLITHIASIS 47 0.0010
923 PLEURAL EFFUSION 62 0.0010
924 BLISTER 57 0.0010
925 PRURITUS 386 0.0010
926 HAEMOPTYSIS 28 0.0010
927 RESPIRATORY DISORDER 30 0.0010
928 FREQUENT BOWEL MOVEMENTS 27 0.0010
929 UNEVALUABLE EVENT 75 0.0010
930 BONE DENSITY DECREASED 31 0.0010
931 ACUTE MYOCARDIAL INFARCTION 29 0.0010
932 HYPERSENSITIVITY 182 0.0010
933 HAEMATOCHEZIA 54 0.0010
934 RASH MACULAR 34 0.0010
935 LIVER DISORDER 43 0.0010
936 EYE PRURITUS 32 0.0010
937 NASOPHARYNGITIS 174 0.0009
938 SWELLING 88 0.0009
939 MYOCARDIAL INFARCTION 164 0.0009
940 SKIN EXFOLIATION 78 0.0009
941 RASH PRURITIC 50 0.0009
942 SKIN IRRITATION 42 0.0009
943 INTERSTITIAL LUNG DISEASE 44 0.0009
944 URTICARIA 152 0.0009
945 EYE IRRITATION 52 0.0009
946 RASH ERYTHEMATOUS 42 0.0009
947 DEATH 756 0.0009
948 ERYTHEMA 180 0.0009
949 FEMUR FRACTURE 27 0.0009
950 PSORIASIS 112 0.0009
951 HAEMORRHAGE 89 0.0009
952 INFUSION RELATED REACTION 56 0.0008
953 SINUSITIS 85 0.0008
954 RHEUMATOID ARTHRITIS 94 0.0008
955 RENAL FAILURE ACUTE 35 0.0008
956 ILL-DEFINED DISORDER 50 0.0008
957 INJECTION SITE MASS 30 0.0008
958 FUNGAL INFECTION 27 0.0008
959 MULTIPLE SCLEROSIS RELAPSE 55 0.0008
960 DRY SKIN 107 0.0008
961 HOT FLUSH 60 0.0008
962 CATARACT 46 0.0008
963 FEBRILE NEUTROPENIA 51 0.0008
964 HYPOACUSIS 33 0.0008
965 GASTROINTESTINAL HAEMORRHAGE 64 0.0008
966 DYSPNOEA EXERTIONAL 28 0.0007
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52 0.0007
968 CEREBROVASCULAR ACCIDENT 122 0.0007
969 COLITIS 27 0.0007
970 FLUSHING 72 0.0007
971 ACNE 53 0.0007
972 EXTRA DOSE ADMINISTERED 28 0.0007
973 FLUID RETENTION 35 0.0007
974 HERPES ZOSTER 39 0.0007
975 DRUG DOSE OMISSION 112 0.0007
976 INJECTION SITE PAIN 200 0.0007
977 RECTAL HAEMORRHAGE 28 0.0007
978 DRUG EFFECT DECREASED 35 0.0006
979 NEOPLASM MALIGNANT 42 0.0006
980 STOMATITIS 38 0.0006
981 COLITIS ULCERATIVE 27 0.0006
982 DYSGEUSIA 44 0.0006
983 CARDIAC FAILURE CONGESTIVE 46 0.0006
984 INJECTION SITE REACTION 39 0.0006
985 MUSCULOSKELETAL PAIN 27 0.0005
986 INJECTION SITE SWELLING 35 0.0005
987 ACCIDENTAL EXPOSURE TO PRODUCT 40 0.0004
988 DEVICE ISSUE 30 0.0003
989 PRODUCT QUALITY ISSUE 42 0.0003
990 INJECTION SITE ERYTHEMA 37 0.0003